Notice Number: NOT-HL-16-461

Key Dates
Release Date: November 8, 2016

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in PAS-15-168 "New Directions in Hematology Research (SHINE-II) (R01)".

The following sections of PAS-15-168 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.847, 93.839

Part 2. Section II. Award Information

Current Language:

Funds Available and Anticipated Number of Awards
NIDDK intends to commit $1,000,000 to fund 2-4 awards in fiscal year 2016.  Future year amounts will depend on annual appropriations.

Revised Language:

Funds Available and Anticipated Number of Awards
NIDDK intends to commit $1,000,000 to fund 2-4 awards in fiscal year 2016.  Future year amounts will depend on annual appropriations.

NHLBI intends to commit $2,000,000 in FY 2018 to fund two to five awards. Future year amounts will depend on annual appropriations.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Manjit Hanspal, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0070
Email: [email protected]

John W. Thomas, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0070
Email: [email protected]

Financial/Grants Management Contact(s)
Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0186
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Manjit Hanspal, PHD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0070
Email: [email protected]